SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Lamers, C. T. J.
Right arrow Articles by Brookhuis, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lamers, C. T. J.
Right arrow Articles by Brookhuis, K. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Dissociable Effects of a Single Dose of Ecstasy (MDMA) on Psychomotor Skills and Attentional Performance

C. T. J. Lamers

c.lamers{at}psychology.unimaas.nl

J. G. Ramaekers

N. D. Muntjewerff

K. L. Sikkema

W. J. Riedel

Experimental Psychopharmacology Unit, Brain and Behaviour Institute, Maastricht University, Maastricht, The Netherlands

N. Samyn

National Institute of Criminalistics and Criminology, Section Toxicology, Brussels, Belgium

N. L. Read

Institute for Transport Studies, University of Leeds, UK

K. A. Brookhuis

Department of Psychology, University of Groningen, The Netherlands

Ecstasy (3,4-methylenedioxymethamphetamine, MDMA) is a psychoactive recreational drug widely used by young people visiting dance parties, and has been associated with poor cognitive function. The current study assessed the influence of a single dose of MDMA 75 mg and alcohol 0.5 g/kg on cognition, psychomotor performance and driving-related task performance. Twelve healthy recreational ecstasy users participated in an experimental study conducted according to a double-blind, double-dummy, placebo-controlled three-way cross-over design. MDMA improved psychomotor performance, such as movement speed and tracking performance in a single task, as well as in a divided attention task. MDMA impaired the ability to predict object movement under divided attention. However, the inability to accurately predict object movement after MDMA may indicate impairment of particular performance skills relevant to driving. There was no effect of MDMA on visual search, planning or retrieval from semantic memory.

Key Words: alcohol • cognition • ecstasy • MDMA • psychomotor performance • traffic safety

Journal of Psychopharmacology, Vol. 17, No. 4, 379-387 (2003)
DOI: 10.1177/0269881103174015


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
K. Kuypers, M. Wingen, and J. Ramaekers
Memory and mood during the night and in the morning after repeated evening doses of MDMA
J Psychopharmacol, November 1, 2008; 22(8): 895 - 903.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
A. C. Parrott, I. S. McGregor, T. M. C. Lee, A. B. Scholey, and M. J. Morgan
International conference on memory (ICOM-4), University of New South Wales, Sydney, Australia, 16 21 July 2006 Ecstasy/MDMA and Memory Symposium
J Psychopharmacol, November 1, 2007; 21(8): 895 - 897.
[PDF]


Home page
J PsychopharmacolHome page
A. C. Parrott
MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress
J Psychopharmacol, March 1, 2006; 20(2): 147 - 163.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
G. J. H. Dumont and R. J. Verkes
A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers
J Psychopharmacol, March 1, 2006; 20(2): 176 - 187.
[Abstract] [PDF]


Home page
Clin. Chem.Home page
F. T. Peters, N. Samyn, C. T.J. Lamers, W. J. Riedel, T. Kraemer, G. de Boeck, and H. H. Maurer
Drug Testing in Blood: Validated Negative-Ion Chemical Ionization Gas Chromatographic-Mass Spectrometric Assay for Enantioselective Measurement of the Designer Drugs MDEA, MDMA, and MDA and Its Application to Samples from a Controlled Study with MDMA
Clin. Chem., October 1, 2005; 51(10): 1811 - 1822.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
A. C. Parrott
Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy
J Psychopharmacol, January 1, 2005; 19(1): 71 - 83.
[Abstract] [PDF]


Home page
J PsychopharmacolHome page
A. C. Parrott, E. Gouzoulis-Meyfrank, J. Rodgers, and N. Solowij
Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects
J Psychopharmacol, December 1, 2004; 18(4): 572 - 576.
[PDF]



Advertisement